Showing 16 - 30 of 87 results
-
Onitilo AA, McCarty CA, Cross DS, Goddard KA, Alexander GL, Delate T,...Williams AE. (2013 January). KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings. Cancer Epidemiol Biomarkers Prev.. 22(1):91-101.
PubMed ID: 23155138
-
Onitilo AA, McCarty CA, Goddard KA, Rahm A, Nekhlyudov L, Aiello Bowles E,...Alford S. (2012 November). Utilization of HER2 genetic testing in a multi-institutional observational study. AMERICAN JOURNAL OF MANAGED CARE. 18(11):704-12.
PubMed ID: 23198713
-
Onitilo AA, Doi SA. R.. (2012 October). Recent data regarding low versus high 131I activity for remnant ablation in differentiated thyroid cancer are not generalizable beyond eligibility criteria. NUCLEAR MEDICINE COMMUNICATIONS. 33(11):1217-8.
-
Simpson M, Hocking WG, Onitilo AA, Mazza JJ, Sanfelippo MJ, Burmester JK, Yale SH. (2012 October). Anti-Phospholipid Antibodies in Patients Undergoing Total Joint Replacement Surgery Thrombosis. Epub Ahead of Print
PubMed ID: 23213505
-
Onitilo AA, Engel JM, Govinda A. (2012 October). Radiation-induced bronchiolitis obliterans organizing pneumonia: a case report and literature review. Clin Adv Hematol Oncol. 10(10):689-91.
PubMed ID: 23187778
-
Onitilo AA, Engel JM, Feigelson HS, James T, McCahill L, Barney T,...Single R. (2012 August). CA2-04: Variation in Mastectomy Rate for Invasive Breast Cancer: Results from the Breast Cancer Surgical Outcomes Study. Clinical Medicine & Research. 10(3):151-2.
PubMed ID: 22904404
-
Onitilo AA, Engel JM, Feigelson HS, James T, Single R, McCahill L, Bowles EA. (2012 August). PS1-16: Patterns of Surgical Care for Ductal Carcinoma In-situ. Clinical Medicine & Research. 10(3):148.
PubMed ID: 22904394
-
Onitilo AA, McCarty CA, Goddard KA, Feigelson HS, Magid DJ, Davis R,...Wellman R. (2012 August). Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst.. 104(17):1293-305.
PubMed ID: 22949432
-
Stankowski RV, Berg RL, Onitilo AA, Engel JM, Doi SA. R., Liang H. (2012 July). High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study. BREAST CANCER RESEARCH AND TREATMENT. 134(1):291-8.
PubMed ID: 22476854
-
Stankowski RV, Onitilo AA, Engel JM, Glurich IE, Doi SA. R., Williams G. (2012 July). Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. CANCER CAUSES & CONTROL. 23(7):991-1008.
PubMed ID: 22527174
-
Berg RL, Onitilo AA, Engel JM, Glurich IE, Johnson JC, Doi SA. R.. (2012 July). Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience. THROMBOSIS RESEARCH. 130(1):27-31.
PubMed ID: 22154240
-
Onitilo AA, Doi SA. R., Barendregt JJ. (2012 July). Methods for the bias adjustment of meta-analyses of published observational studies. J Eval Clin Pract. [Epub Ahead Of Print]
PubMed ID: 22845171
-
Onitilo AA, Engel JM, Aryal G. (2012 June). Hereditary Diffuse Gastric Cancer: A Family Diagnosis and Treatment. Clinical Medicine & Research. Epub Ahead of Print
PubMed ID: 22723466
-
Stankowski RV, Onitilo AA, Engel JM, Glurich IE, Doi SA. R., Williams GH. (2012 June). Diabetes and cancer I: risk, survival, and implications for screening. CANCER CAUSES & CONTROL. 23(6):967-81.
PubMed ID: 22552844
-
Onitilo AA, Engel JM, Depke JL, Resnick JM, Demos JM. (2012 June). Digital ischemia as a paraneoplastic consequence of squamous cell lung carcinoma. WMJ. 111(3):138-42; quiz 142.
